Vertaling van "applications total number of " (Nederlands → Frans) :

Commission for the establishment of retail pharmacies; French language chamber Total number of applications Total number of decisions
Commission for the establishment of retail pharmacies; French language chamber Total number of applications Total number of decisions

There was an increase in the total number of applications for evaluation, with a significant rise in particular in the number of PSUR.
There was an increase in the total number of applications for evaluation, with a significant rise in particular in the number of PSUR.

Total number of deaths 103 800 1 265 2 853 10 341 42 371 46 577 393 (all causes) Total internal causes 97 508 891 1 152 8 798 40 899 45 384 384 Infectious and parasitic 1 308 30 59 112 498 600 9 diseases (except tuberculosis) Tumours 28 041 104 421 4 258 15 422 7 824 12 Endocrine and blood 2 828 25 35 159 1 128 1 471 10 diseases Mental disorders 2 464 4 61 163 561 1 664 11 Diseases of the nervous 3 419 58 73 195 1 268 1 818 7 system and the sense organs Diseases of the circulatory 28 501 20 180 1 875 11 117 15 157 152 system except cerebrovascular diseases
Total des décès 103.800 1.265 2.853 10.341 42.371 46.577 393 (toutes causes) Total causes internes 97.508 891 1.152 8.798 40.899 45.384 384 Maladies infectieuses et parasitaires 1.308 30 59 112 498 600 9 (sauf tuberculose) tumeurs 28.041 104 421 4.258 15.422 7.824 12 Maladies endocriniennes, maladie du 2.828 25 35 159 1.128 1.471 10 sang Troubles mentaux 2.464 4 61 163 561 1.664 11 Maladies du système nerveux et des 3.419 58 73 195 1.268 1.818 7 organes de sens Maladies de l’appareil circulatoire sauf 28.501 20 180 1.875 11.117 15.157 152 maladies vasculaires cérébrales Maladies vasculaires cérébrales 9.453 11 63 460 3.296 5.594 29 Maladies de l’appareil respiratoire 10.672 26 46 456 4.275 5.808 61 Maladies de l’appareil digestif 4.519 5 112 799 1.711 1.882 10 Maladies de l’appareil uro-génital 1.504 1 13 54 533 896 7

List and total number of new cases for that month
Liste et nombre total de nouveaux cas pour le mois en question

Other reviews Total number of files opened after suspicion of infringement
Other reviews Total number of files opened after suspicion of infringement

Total number of S. aureus isolated from clinical samples, preferentially counted once per patient-admission
- Nombre total de S. aureus isolés à partir des prélèvements cliniques, de préférence comptés une seule fois par admission-patient

Some achievements and figures for the Veterinary Medicines unit in 2007 KPIs and measurement results The most important KPI for this unit is the proportion of the number of finalised applications to the number of new, submitted applications, as a measure of the evolution of the unit’s backlog.
Some achievements and figures for the Veterinary Medicines unit in 2007 KPIs and measurement results The most important KPI for this unit is the proportion of the number of finalised applications to the number of new, submitted applications, as a measure of the evolution of the unit’s backlog.

Veterinary medicines Unit For the fifth year in a row the number of applications closed for obtaining marketing authorisation (MA) within the Veterinary medicines Unit has exceeded the number of new applications submitted.
Veterinary medicines Unit For the fifth year in a row the number of applications closed for obtaining marketing authorisation (MA) within the Veterinary medicines Unit has exceeded the number of new applications submitted.

For 2007, an analysis has been performed of the number of submitted applications versus the number of MA of medicines for human use granted.
For 2007, an analysis has been performed of the number of submitted applications versus the number of MA of medicines for human use granted.

In 2008, there was a significant increase observed in the number of applications for clinical trials and amendments (changes to an existing file) and of the percentage of phase I trials. The absolute number of non-commercial (“academic”) trials remained stable.
In 2008, there was a significant increase observed in the number of applications for clinical trials and amendments (changes to an existing file) and of the percentage of phase I trials. The absolute number of non-commercial (“academic”) trials remained stable.